Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation
Recruiting
Investigated Drugs:
Study of Fecal Microbiota Transplantation combined with atezolizumab and bevacizumab in patients with unresectable liver cancer who progressed after initial treatment
Recruiting
Investigated Diseases:Investigated Drugs:
Advanced hepatocellular carcinoma patients: assessing atezolizumab drug combination and other treatment sequences
Not yet recruiting
Investigated Diseases:Investigated Drugs:
DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs:- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST TROP2 CONJUGATED TO N-((7S,15S)-7-BENZYL-17-(((1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL-10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12H-BENZO[DE]PYRANO[3′,4′:6,7] INDOLIZINO[1,2-B]QUINOLIN-1-YL)AMINO)-15-METHYL-2,5,8,11,17-PENTAOXO-14-OXA-3,6,9,12-TETRAAZAHEPTADECYL)-6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANAMIDE
- BNT327
A study to evaluate the safety and effectiveness of AZD9793 in adults with advanced or metastatic liver cancer
Not yet recruiting
Investigated Diseases:
Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors
Not yet recruiting
Investigated Diseases:Investigated Drugs:
Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers
Not yet recruiting
Investigated Diseases:
